Skip to main content
Book Chapter

Clinical Trials in Neurodegeneration

  • Hardiman O
  • Kelly J
  • Bak T
  • et al.
Springer International Publishing, (2016), 289-303
DOI: 10.1007/978-3-319-23309-3_16
N/ACitations
Citations of this article
4Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Over the past two decades, there have been significant advances in the management and treatment of many neurodegenerative diseases. For example, the development of cholinergic agonists for Alzheimer’s Disease (AD) have improved both functional abilities and quality of life, and newer monoamine oxidase inhibitors and transdermal dopaminergic patches improve function in Parkinsons Disease (PD).

Cite

CITATION STYLE

APA

Hardiman, O., Kelly, J. A., Bak, T. H., Elamin, M., Mihaila, D. L., Shaw, P. J., … Shefner, J. M. (2016). Clinical Trials in Neurodegeneration. In Neurodegenerative Disorders (pp. 289–303). Springer International Publishing. https://doi.org/10.1007/978-3-319-23309-3_16

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free